On the validity of the J-integral as a measure of the transverse intralaminar fracture energy of glass fiber-reinforced polyurethanes with nonlinear material behavior

Autor: Montenegro, D.M., Canal, L.P., Botsis, J., Zogg, M., Studart, A.R., Wegener, K.

Publikováno v: In International Journal of Solids and Structures 15 May 2018 139-140:15-28

Survival advantage of heterozygous factor V Leiden carriers in murine sepsis

Autor: Kerschen, E., Hernandez, I., Zogg, M., Maas, M., Weiler, H. ^*

Publikováno v: In Journal of Thrombosis and Haemostasis June 2015 13(6):1073-1080

Identification of marker genes to monitor residual iPSCs in iPSC-derived products.

Autor: Lemmens M; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Perner J; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Potgeter L; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Zogg M; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Thiruchelvam S; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Müller M; Chemical Biology and Therapeutics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland., Doll T; Chemical Biology and Therapeutics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland., Werner A; Chemical Biology and Therapeutics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland., Gilbart Y; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Couttet P; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Martus HJ; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Libertini S; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: silvana.libertini@novartis.com.

Publikováno v: Cytotherapy [Cytotherapy] 2023 Jan; Vol. 25 (1), pp. 59-67. Date of Electronic Publication: 2022 Oct 29.

P10-02 Parabens and UV-filters activating retinoic acid-related orphan receptor γ(t)

Autor: Kley, M., Inderbinen, S.G., Zogg, M., Sellner, M., Fischer, A., Kędzierski, J., Boudon, S., Jetten, A.M., Smieško, M., Odermatt, A.

Publikováno v: In Toxicology Letters 1 September 2022 368 Supplement:S155-S155

Activation of retinoic acid-related orphan receptor γ(t) by parabens and benzophenone UV-filters.

Autor: Inderbinen SG; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland; Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Missionsstrasse 64, 4055 Basel, Switzerland., Kley M; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland; Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Missionsstrasse 64, 4055 Basel, Switzerland., Zogg M; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland., Sellner M; Computational Pharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland., Fischer A; Computational Pharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland., Kędzierski J; Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Missionsstrasse 64, 4055 Basel, Switzerland; Computational Pharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland., Boudon S; Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Missionsstrasse 64, 4055 Basel, Switzerland., Jetten AM; Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, 111. T.W. Alexander Drive, Research Triangle Park, NC 27709, USA., Smieško M; Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Missionsstrasse 64, 4055 Basel, Switzerland; Computational Pharmacy, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland., Odermatt A; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland; Swiss Centre for Applied Human Toxicology and Department of Pharmaceutical Sciences, University of Basel, Missionsstrasse 64, 4055 Basel, Switzerland. Electronic address: alex.odermatt@unibas.ch.

Publikováno v: Toxicology [Toxicology] 2022 Apr 15; Vol. 471, pp. 153159. Date of Electronic Publication: 2022 Mar 23.